Search research articles
Contact Us
Filters
Showing results (11-20 of 102) with videos related to
Page
of 11
Sort By:
Nature Reviews. Immunology
|
May 15, 2023
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
Kenji Chamoto, Tomonori Yaguchi, Masaki Tajima, et al.
Elife
|
March 4, 2020
Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
Alok Kumar, Kenji Chamoto, Partha S Chowdhury, et al.
Cancer Immunology Research
|
August 26, 2018
PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8<sup>+</sup> T Cells and Facilitates Anti-PD-1 Therapy
Partha S Chowdhury, Kenji Chamoto, Alok Kumar, et al.
Biomedical Research (Tokyo, Japan)
|
March 7, 2009
Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells
Yoshinori Narita, Daiko Wakita, Takayuki Ohkur, et al.
Trends in Cell Biology
|
September 18, 2023
Spermidine - an old molecule with a new age-defying immune function
Kenji Chamoto, Baihao Zhang, Masaki Tajima, et al.
Cancer Science
|
April 20, 2026
Multifunctional Role of Mitochondrial Fatty Acid Oxidation in Cancer Immunotherapy and Aging
Koji Kitaoka, Shuhei Hirose, Yu Wang, et al.
International Immunology
|
December 25, 2007
CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung
Shigeru Ashino, Daiko Wakita, Yue Zhang, et al.
Science Translational Medicine
|
November 30, 2022
Chemical induction of splice-neoantigens attenuates tumor growth in a preclinical model of colorectal cancer
Shingo Matsushima, Masahiko Ajiro, Kei Iida, et al.
Cellular Immunology
|
November 12, 2003
Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo
Junko Matsuzaki, Takemasa Tsuji, Kenji Chamoto, et al.
Cancer Science
|
February 16, 2010
3-Methylcholanthrene-induced transforming growth factor-beta-producing carcinomas, but not sarcomas, are refractory to regulatory T cell-depletion therapy
Kenji Chamoto, Daiko Wakita, Takayuki Ohkuri, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 102) with videos related to
Sort By:
Page
of 11
Nature Reviews. Immunology
|
May 15, 2023
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
Kenji Chamoto, Tomonori Yaguchi, Masaki Tajima, et al.
Elife
|
March 4, 2020
Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
Alok Kumar, Kenji Chamoto, Partha S Chowdhury, et al.
Cancer Immunology Research
|
August 26, 2018
PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8<sup>+</sup> T Cells and Facilitates Anti-PD-1 Therapy
Partha S Chowdhury, Kenji Chamoto, Alok Kumar, et al.
Biomedical Research (Tokyo, Japan)
|
March 7, 2009
Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells
Yoshinori Narita, Daiko Wakita, Takayuki Ohkur, et al.
Trends in Cell Biology
|
September 18, 2023
Spermidine - an old molecule with a new age-defying immune function
Kenji Chamoto, Baihao Zhang, Masaki Tajima, et al.
Cancer Science
|
April 20, 2026
Multifunctional Role of Mitochondrial Fatty Acid Oxidation in Cancer Immunotherapy and Aging
Koji Kitaoka, Shuhei Hirose, Yu Wang, et al.
International Immunology
|
December 25, 2007
CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung
Shigeru Ashino, Daiko Wakita, Yue Zhang, et al.
Science Translational Medicine
|
November 30, 2022
Chemical induction of splice-neoantigens attenuates tumor growth in a preclinical model of colorectal cancer
Shingo Matsushima, Masahiko Ajiro, Kei Iida, et al.
Cellular Immunology
|
November 12, 2003
Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo
Junko Matsuzaki, Takemasa Tsuji, Kenji Chamoto, et al.
Cancer Science
|
February 16, 2010
3-Methylcholanthrene-induced transforming growth factor-beta-producing carcinomas, but not sarcomas, are refractory to regulatory T cell-depletion therapy
Kenji Chamoto, Daiko Wakita, Takayuki Ohkuri, et al.
Page
of 11